A Note from Lotame’s COO, Adam Lehman
We need to correct some mis-impressions generated by a new Stanford report, and related press coverage. Notwithstanding the implications of the report:
- Lotame does not buy, sell or otherwise use information related to drug use frequency.
- Lotame does not buy, sell or otherwise use usernames or other personally-identifiable information (including name, address, e-mail address, phone number or government identifiers). If a publisher passes usernames to us, our systems are designed so that this information does not qualify as a behavior, get categorized into any behavioral segment used for analytics or ad targeting, or otherwise get associated back to an anonymous user profile.
We take consumer privacy seriously at Lotame, and work hard to both create progressive privacy policies and practices, and then operate in accordance with those high standards.
By way of example, we have been honoring Do-Not-Track headers for six months (since the first DNT tool was released by Firefox). We didn’t feel the need to beat our chests about taking this step – we just thought it was the right thing to do.
It’s always disappointing when we need to beat back a gratuitous sideswipe like the references to Lotame in the Stanford study (which was purportedly focused on user names and User IDs). But we realize these types of stories are an occupational hazard when working with data; and we remain as committed as ever to being a progressive industry leader when it comes to our consumer privacy policies and practices.